APUS Earnings

Quarterly EPS
$-2.57
Q2 2025
$-1.40
Q3 2025
$-0.05
Q4 2025
$-2.26
Q1 2026
$-11.77
Q2 2026
Latest RevenueN/A
Latest Net Income-20173129
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$11.770-20173129-358.0%
Q1 2026-$2.260-35059852
Q4 2025-$0.050-1155292
Q3 2025-$1.400-1781255
Q2 2025-$2.570-2662193
Apimeds Pharmaceuticals US (APUS) — Earnings